Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 January 2019 | Story Ruan Bruwer | Photo Varsity Cup
Varsity Cup
Shimlas scrumhalf, Rewan Kruger, played for the Junior Springboks last year and he was also jointly named Junior Player of the Year for the Shimlas alongside Lubabalo Dobela.

A fresh and inexperienced Shimla team, branded as the youngest squad ever, came two log points short of reaching the semi-finals of the Varsity Cup in last season's tournament. Ten of the players in the squad were still U19 last year. The 2018 rugby year proved to be a reconstructive one for the Shimlas after they parted ways with several members of their team in 2017.

After winning three of their first four encounters, including two away fixtures, the Shimlas were set for a spot in the semi-finals, which could possibly have been a home game. The three victories were against the defending champions Tuks by 19-17, 44-24 against Wits, and a 32-27 win over Ikeys.

The Shimlas played a total of 17 matches in 2018, claiming victory in 12. They finished fourth at the University Sport South Africa (USSA) tournament and won the Mangaung Metro league.

Johan Kotze, Shimla captain and prop, was titled ‘Senior Player of the Year’.

In the same breath, Lubabalo Dobela and Rewan Kruger, who both played for the Junior Springboks, were jointly selected as the ‘Junior Players of the Year’.

Vishuis was named the country’s best hostel rugby team for the third consecutive year. They defeated Patria of the North-West University in the finals by 55-29.

The UFS U20 team won all four of their matches in the group stage of the Young Guns competition before they lost to Tuks in the semi-final.

The Kovsie Sevens team won the bowl competition at the USSA tournament and at the Varsity Sevens they ended in 6th position.

News Archive

Counterfeit HIV / AIDS drugs must be dealt with
2006-02-16

Some of the guests attending the lecture were from the left Prof Johan Henning (Dean:  UFS Faculty of Law), Dr Jayasuriya, Prof Voet du Plessis (Head: UFS Department of Mercantile Law) and Dr Ezekiel Moraka (Vice-Rector:  Student Affairs at the UFS).
Photo: Stephen Collett

Counterfeit HIV / AIDS drugs must be dealt with

An international legal expert who has worked with various UN agencies has called on governments to deal quickly and decisively with people dealing in counterfeit HIV / AIDS drugs.

The Vice-President of the Global Jurists Foundation and former head of the UNAIDS secretariat in Pakistan, Dr Dayanath Jayasuriya, was speaking at the University of the Free State in Bloemfontein.

Delivering a guest lecture on HIV/ AIDS and human rights in developing countries, Dr Jayasuriya said counterfeit drugs were spreading at an alarming rate throughout the world.  He said that in particular counterfeit HIV / AIDS drugs contribute to the vulnerability of persons living with HIV / AIDS.

“Only a few countries have integrated anti-counterfeit drug provisions into national legislation on medicinal drugs” he said.
According to Dr Jayasuriya, the violation of the rights of people living with HIV / AIDS is continuing despite the fact that many governments have adopted various charters and declarations that are meant to guarantee the human rights of citizens.

He said these violations have included the brutal murder of persons with HIV / AIDS.

Other violations include verbal abuse and physical injuries through acts of torture; deprivation or denial of access to employment; medical facilities, including drugs; accommodation; food; social service benefits; insurance; custody of children, and so on.

“In recorded human history HIV / AIDS is by no means the first ever major public health epidemic to confront human kind. However, none of the other epidemics generated the same degree and intensity of human rights concerns,” Dr Jayasuriya said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept